Genentech has entered into biotech deals with Arrayit to purchase a drug discovery tool for $138,000.
Arrayit Corporation reports that pharmaceutical giant Genentech has purchased Arrayit's patented technology to accelerate drug discovery, as part of the biotech deals.
Genentech purchased Arrayit's NanoPrint LM60 Microarrayer Platform including a manufacturing robot, printing pins and consumables for $138,000, as part of the biotech deals.
Genentech scientists employ Arrayit protein microarray technology to screen protein-protein interactions in a massively parallel manner as a means of speeding the discovery of new protein drugs.
Report: Partnering Deals and Alliances with Genentech
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity